Tocilizumab
Quick Overview
| Attribute | Value |
|---|---|
| Drug Name | Tocilizumab |
| DrugBank ID | DB06273 |
| KG Predictions | 14 |
| DL Predictions (≥0.7) | 0 |
| Evidence Level | L5 |
| NPRA Status | Approved |
Sample Brand Names in Malaysia
Predicted Indications
This drug has 14 knowledge graph predictions and 0 high-confidence deep learning predictions.
Top KG Predictions
| Indication | Source |
|---|---|
| Kimura disease | KG |
| rheumatoid arthritis | KG |
| Castleman disease | KG |
| temporal arteritis | KG |
| juvenile arthritis due to defect in LACC1 | KG |
| spondyloarthropathy | KG |
| juvenile idiopathic arthritis | KG |
| Kimura disease | KG |
| rheumatoid arthritis | KG |
| Castleman disease | KG |
FHIR Resources
Access drug data via FHIR R4 API:
- MedicationKnowledge:
/fhir/MedicationKnowledge/DB06273
Related Resources
| Resource | Link |
|---|---|
| DrugBank | View on DrugBank |
| PubMed | Search PubMed |
| ClinicalTrials.gov | Search Trials |
Disclaimer
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.